Table of Contents

2019-2024 Global Intravenous Solutions Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Intravenous Solutions Consumption 2014-2024
  • 2.1.2 Intravenous Solutions Consumption CAGR by Region
• 2.2 Intravenous Solutions Segment by Type
  • 2.2.1 Crystalloids
  • 2.2.2 Colloids
  • 2.2.3 Others
• 2.3 Intravenous Solutions Consumption by Type
  • 2.3.1 Global Intravenous Solutions Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Intravenous Solutions Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Intravenous Solutions Sale Price by Type (2014-2019)
• 2.4 Intravenous Solutions Segment by Application
  • 2.4.1 Basic IV Solutions
  • 2.4.2 Nutrient Infusion Solution
  • 2.4.3 Others
• 2.5 Intravenous Solutions Consumption by Application
  • 2.5.1 Global Intravenous Solutions Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Intravenous Solutions Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Intravenous Solutions Sale Price by Application (2014-2019)

3 Global Intravenous Solutions by Players

• 3.1 Global Intravenous Solutions Sales Market Share by Players
  • 3.1.1 Global Intravenous Solutions Sales by Players (2017-2019)
  • 3.1.2 Global Intravenous Solutions Sales Market Share by Players (2017-2019)
• 3.2 Global Intravenous Solutions Revenue Market Share by Players
  • 3.2.1 Global Intravenous Solutions Revenue by Players (2017-2019)
  • 3.2.2 Global Intravenous Solutions Revenue Market Share by Players (2017-2019)
• 3.3 Global Intravenous Solutions Sale Price by Players
• 3.4 Global Intravenous Solutions Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Intravenous Solutions Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Intravenous Solutions Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Intravenous Solutions by Regions

• 4.1 Intravenous Solutions by Regions
  • 4.1.1 Global Intravenous Solutions Consumption by Regions
  • 4.1.2 Global Intravenous Solutions Value by Regions
• 4.2 Americas Intravenous Solutions Consumption Growth
• 4.3 APAC Intravenous Solutions Consumption Growth
• 4.4 Europe Intravenous Solutions Consumption Growth
• 4.5 Middle East & Africa Intravenous Solutions Consumption Growth

5 Americas

• 5.1 Americas Intravenous Solutions Consumption by Countries
  • 5.1.1 Americas Intravenous Solutions Consumption by Countries (2014-2019)
  • 5.1.2 Americas Intravenous Solutions Value by Countries (2014-2019)
• 5.2 Americas Intravenous Solutions Consumption by Type
• 5.3 Americas Intravenous Solutions Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Intravenous Solutions Consumption by Countries
  • 6.1.1 APAC Intravenous Solutions Consumption by Countries (2014-2019)
  • 6.1.2 APAC Intravenous Solutions Value by Countries (2014-2019)
• 6.2 APAC Intravenous Solutions Consumption by Type
• 6.3 APAC Intravenous Solutions Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Intravenous Solutions by Countries
  • 7.1.1 Europe Intravenous Solutions Consumption by Countries (2014-2019)
  • 7.1.2 Europe Intravenous Solutions Value by Countries (2014-2019)
• 7.2 Europe Intravenous Solutions Consumption by Type
• 7.3 Europe Intravenous Solutions Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Intravenous Solutions by Countries
  • 8.1.1 Middle East & Africa Intravenous Solutions Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Intravenous Solutions Value by Countries (2014-2019)
• 8.2 Middle East & Africa Intravenous Solutions Consumption by Type
• 8.3 Middle East & Africa Intravenous Solutions Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Intravenous Solutions Distributors
• 10.3 Intravenous Solutions Customer

11 Global Intravenous Solutions Market Forecast

• 11.1 Global Intravenous Solutions Consumption Forecast (2019-2024)
• 11.2 Global Intravenous Solutions Forecast by Regions
  • 11.2.1 Global Intravenous Solutions Forecast by Regions (2019-2024)
  • 11.2.2 Global Intravenous Solutions Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Intravenous Solutions Forecast by Type
• 11.8 Global Intravenous Solutions Forecast by Application

12 Key Players Analysis

• 12.1 Baxter
  • 12.1.1 Company Details
  • 12.1.2 Intravenous Solutions Product Offered
  • 12.1.3 Baxter Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Baxter News
• 12.2 Hospira
  • 12.2.1 Company Details
  • 12.2.2 Intravenous Solutions Product Offered
  • 12.2.3 Hospira Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Hospira News
• 12.3 B. Braun Melsungen
  • 12.3.1 Company Details
  • 12.3.2 Intravenous Solutions Product Offered
  • 12.3.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 B. Braun Melsungen News
• 12.4 Fresenius Kabi
  • 12.4.1 Company Details
  • 12.4.2 Intravenous Solutions Product Offered
  • 12.4.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Fresenius Kabi News
• 12.5 Claris Lifesciences
  • 12.5.1 Company Details
  • 12.5.2 Intravenous Solutions Product Offered
  • 12.5.3 Claris Lifesciences Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Claris Lifesciences News
• 12.6 Grifols
  • 12.6.1 Company Details
  • 12.6.2 Intravenous Solutions Product Offered
  • 12.6.3 Grifols Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Grifols News
• 12.7 Vifor Pharma
  • 12.7.1 Company Details
  • 12.7.2 Intravenous Solutions Product Offered
  • 12.7.3 Vifor Pharma Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Vifor Pharma News
• 12.8 JW Life Science
  • 12.8.1 Company Details
  • 12.8.2 Intravenous Solutions Product Offered
  • 12.8.3 JW Life Science Intravenous Solutions Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 JW Life Science News

13 Research Findings and Conclusion

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.

The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.

Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.

USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.

The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Intravenous Solutions market will register a 2.0% CAGR in terms of revenue, the global market size will reach US$ 1930 million by 2024, from US$ 1710 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Solutions business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions market by product type, application, key manufacturers and key regions and countries.

This study considers the Intravenous Solutions value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Crystalloids
Colloids
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Basic IV Solutions
Nutrient Infusion Solution
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Intravenous Solutions consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Intravenous Solutions market by identifying its various subsegments.
Focuses on the key global Intravenous Solutions manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Solutions with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous Solutions submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.